Cancer and the chemokine network.
Balkwill
Fran
F
Cancer Research UK Translational Oncology Laboratory, Barts and The London, Queen Mary's Medical School, Charterhouse Square, London EC1M 6BQ, UK. frances.balkwill@cancer.org.uk
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000503:physiopathology; D018925:Chemokines / Q000037:antagonists & inhibitors / Q000145:classification / Q000502:physiology*; D002634:Chemotaxis, Leukocyte / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D016246:Lymphocytes, Tumor-Infiltrating / Q000502:physiology; D008262:Macrophage Activation / Q000502:physiology; D051379:Mice; D008819:Mice, Nude; D008954:Models, Biological; D009361:Neoplasm Invasiveness / Q000503:physiopathology; D009362:Neoplasm Metastasis / Q000503:physiopathology; D009363:Neoplasm Proteins / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors / Q000502:physiology; D023041:Xenograft Model Antitumor Assays
D000970:Antineoplastic Agents; D018925:Chemokines; D009363:Neoplasm Proteins; D019707:Receptors, Chemokine